The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication

被引:11
|
作者
Van Cor-Hosmer, Sarah K. [1 ]
Daddacha, Waaqo [1 ]
Kelly, Z. [1 ]
Tsurumi, Amy [1 ]
Kennedy, Edward M. [1 ]
Kim, Baek [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14648 USA
关键词
HIV-1; Reverse transcriptase; dNTP binding affinity; Cellular dNTP pools; Steady and presteady kinetics; MURINE LEUKEMIA-VIRUS; DNA-SYNTHESIS; AMINO-ACID; DRUG-RESISTANCE; STERIC GATE; CELL-CYCLE; HIV-1; FIDELITY; LAMIVUDINE; MACROPHAGE;
D O I
10.1016/j.virol.2011.11.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) has a unique tight binding to dNTP substrates. Structural modeling of Ala-114 of HIV-1 RT suggests that longer side chains at this residue can reduce the space normally occupied by the sugar moiety of an incoming dNTP. Indeed, mutations at Ala-114 decrease the ability of RT to synthesize DNA at low dNTP concentrations and reduce the dNTP-binding affinity (K-d) of RT. However, the K-d values of WT and A114C RT remained equivalent with an acyclic dNTP substrate. Finally, mutant A114 RT HIV-1 vectors displayed a greatly reduced transduction in nondividing human lung fibroblasts (HLFs), while WT HIV-1 vector efficiently transduced both dividing and nondividing HLFs.Together these data support that the A114 residue of HIV-1 RT plays a key mechanistic role in the dNTP binding of HIV-1 RT and the unique viral infectivity of target cell types with low dNTP pools. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 50 条
  • [21] The incorporation of nucleoside analogs by human immunodeficiency virus type 1 reverse transcriptase decreases in the presence of polyamines
    Bakhanashvili, Mary
    Rahav, Galia
    FEBS LETTERS, 2006, 580 (22): : 5363 - 5370
  • [22] Insertions in the β3-β4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity
    Eggink, Dirk
    Huigen, Marleen C. D. G.
    Boucher, Charles A. B.
    Gotte, Matthias
    Nijhuis, Monique
    ANTIVIRAL RESEARCH, 2007, 75 (02) : 93 - 103
  • [23] Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection
    Sakuragi, Sayuri
    Shioda, Tatsuo
    Sakuragi, Jun-ichi
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 3382 - 3388
  • [24] The Glutamine Side Chain at Position 91 on the β5a-β5b Loop of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Required for Stabilizing the dNTP Binding Pocket
    Pandey, Nootan
    Mishra, Chaturbhuj A.
    Manvar, Dinesh
    Upadhyay, Alok K.
    Talele, Tanaji T.
    Comollo, Thomas W.
    Kaushik-Basu, Neerja
    Pandey, Virendra N.
    BIOCHEMISTRY, 2011, 50 (37) : 8067 - 8077
  • [25] MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    CLARK, P
    WHITMER, J
    FRANK, P
    TANTILLO, C
    ARNOLD, E
    HUGHES, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) : 472 - 483
  • [26] Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and moloney murine leukemia virus reverse transcriptase
    Gao, HQ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1097 - 1113
  • [27] In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins
    Sun, RWY
    Yu, WY
    Sun, HZ
    Che, CM
    CHEMBIOCHEM, 2004, 5 (09) : 1293 - 1298
  • [28] The interaction of the reverse transcriptase of human immunodeficiency virus type 1 with 3'-terminally mispaired DNA
    Bakhanashvili, M
    Hizi, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 334 (01) : 89 - 96
  • [29] Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for Use in cDNA Synthesis
    Atsushi Konishi
    Mayu Shinomura
    Kiyoshi Yasukawa
    Applied Biochemistry and Biotechnology, 2013, 169 : 77 - 87
  • [30] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957